Ramoplanin as a novel therapy for Neisseria gonorrhoeae infection: an in vitro and in vivo study in Galleria mellonella

References

1. Alirol E, Wi TE, Bala M, Bazzo ML, Chen X-S et al. Multidrug-resistant gonorrhea: a research and development roadmap to discover new medicines. PLoS Med 2017; 14:e1002366 [View Article] [PubMed]
   [Google Scholar]
2. Malin JJ, de Leeuw E. Therapeutic compounds targeting lipid II for antibacterial purposes. Infect Drug Resist 2019; 12:2613–2625 [View Article] [PubMed]
   [Google Scholar]
3. Brunati C, Thomsen TT, Gaspari E, Maffioli S, Sosio M et al. Expanding the potential of NAI-107 for treating serious ESKAPE pathogens: synergistic combinations against gram-negatives and bactericidal activity against non-dividing cells. J Antimicrob Chemother 2018; 73:414–424 [View Article] [PubMed]
   [Google Scholar]
4. Kurz M, Guba W. 3D structure of ramoplanin: a potent inhibitor of bacterial cell wall synthesis. Biochemistry 1996; 35:12570–12575 [View Article] [PubMed]
   [Google Scholar]
5. Fang X, Tiyanont K, Zhang Y, Wanner J, Boger D et al. The mechanism of action of ramoplanin and enduracidin. Mol Biosyst 2006; 2:69–76 [View Article] [PubMed]
   [Google Scholar]
6. Pallanza R, Berti M, Scotti R, Randisi E, Arioli V. A-16686, a new antibiotic from actinoplanes II. Biological properties. J Antibiot 1984; 37:318–324 [View Article]
   [Google Scholar]
7. Ciabatti R, Maffioli SI, Panzone G, Canavesi A, Michelucci E et al. Synthesis and preliminary biological characterization of new semisynthetic derivatives of ramoplanin. J Med Chem 2007; 50:3077–3085 [View Article] [PubMed]
   [Google Scholar]
8. Stražić Novaković D, Galić N. Comprehensive degradation study of lipoglycodepsipeptide antibiotic ramoplanin by liquid chromatography and mass spectrometry. Talanta Open 2022; 5:100118 [View Article]
   [Google Scholar]
9. Cheng M, Huang JX, Ramu S, Butler MS, Cooper MA. Ramoplanin at bactericidal concentrations induces bacterial membrane depolarization in Staphylococcus aureus. Antimicrob Agents Chemother 2014; 58:6819–6827 [View Article] [PubMed]
   [Google Scholar]
10. Mathur H, O’Connor PM, Hill C, Cotter PD, Ross RP. Analysis of anti-clostridium difficile activity of thuricin CD, vancomycin, metronidazole, ramoplanin, and actagardine, both singly and in paired combinations. Antimicrob Agents Chemother 2013; 57:2882–2886 [View Article] [PubMed]
    [Google Scholar]
11. Freeman J, Baines SD, Jabes D, Wilcox MH. Comparison of the efficacy of ramoplanin and vancomycin in both in vitro and in vivo models of clindamycin-induced Clostridium difficile infection. J Antimicrob Chemother 2005; 56:717–725 [View Article] [PubMed]
    [Google Scholar]
12. Citron DM, Merriam CV, Tyrrell KL, Warren YA, Fernandez H et al. In vitro activities of ramoplanin, teicoplanin, vancomycin, linezolid, bacitracin, and four other antimicrobials against intestinal anaerobic bacteria. Antimicrob Agents Chemother 2003; 47:2334–2338 [View Article] [PubMed]
    [Google Scholar]
13. Tsuchiya K, Kondo M, Oishi T, Yamazaki T. Enduracidin, A New Antibiotic III in vitro and in vitro antimicrobial activity. J Antibiot 1968; 21:147–153 [View Article]
    [Google Scholar]
14. McCafferty DG, Cudic P, Frankel BA, Barkallah S, Kruger RG et al. Chemistry and biology of the ramoplanin family of peptide antibiotics. Biopolymers 2002; 66:261–284 [View Article] [PubMed]
    [Google Scholar]
15. Wong MT, Kauffman CA, Standiford HC, Linden P, Fort G et al. Effective suppression of vancomycin-resistant Enterococcus species in asymptomatic gastrointestinal carriers by a novel glycolipodepsipeptide, ramoplanin. Clin Infect Dis 2001; 33:1476–1482 [View Article] [PubMed]
    [Google Scholar]
16. Liu H, Taylor TH, Pettus K, Trees D, Munson E. Assessment of etest as an alternative to agar dilution for antimicrobial susceptibility testing of Neisseria gonorrhoeae. J Clin Microbiol 2014; 52:1435–1440 [View Article] [PubMed]
    [Google Scholar]
17. Clinical and Laboratory Standards Institute 2014. Performance standards for antimicrobial susceptibility testing: twenty-third informational supplement. In CLSI Document, Approved Standard M100-S24 Wayne, PA: Clinical and Laboratory Standards Institute; 2010
    [Google Scholar]
18. Hofkens N, Gestels Z, Abdellati S, Baetselier I, Gabant P et al. Microbisporicin (NAI-107) protects Galleria Mellonella from infection with Neisseria Gonorrhoeae. Microbiol Spectr 2023e0282523 [View Article] [PubMed]
    [Google Scholar]
19. Dijokaite A, Humbert MV, Borkowski E, La Ragione RM, Christodoulides M. Establishing an invertebrate Galleria mellonella greater wax moth larval model of Neisseria gonorrhoeae infection. Virulence 2021; 12:1900–1920 [View Article] [PubMed]
    [Google Scholar]
20. Chibebe Junior J, Fuchs BB, Sabino CP, Junqueira JC, Jorge AOC et al. Photodynamic and antibiotic therapy impair the pathogenesis of Enterococcus faecium in a whole animal insect model. PLoS One 2013; 8:e55926 [View Article] [PubMed]
    [Google Scholar]
21. Unemo M, Golparian D, Sánchez-Busó L, Grad Y, Jacobsson S et al. The novel 2016 WHO Neisseria gonorrhoeae reference strains for global quality assurance of laboratory investigations: phenotypic, genetic and reference genome characterization. J Antimicrob Chemother 2016; 71:3096–3108 [View Article] [PubMed]
    [Google Scholar]
22. Griffiss JM, Schneider H, Mandrell RE, Yamasaki R, Jarvis GA et al. Lipooligosaccharides: the principal glycolipids of the neisserial outer membrane. Rev Infect Dis 1988; 10:S287–S295 [View Article] [PubMed]
    [Google Scholar]
23. Bertani B, Ruiz N. Function and biogenesis of Lipopolysaccharides. EcoSal Plus 2018; 8: [View Article] [PubMed]
    [Google Scholar]
24. Derrick JP, Urwin R, Suker J, Feavers IM, Maiden MC. Structural and evolutionary inference from molecular variation in Neisseria porins. Infect Immun 1999; 67:2406–2413 [View Article] [PubMed]
    [Google Scholar]
25. Manoharan-Basil S, Abdellati S, Laumen J, Kenyon C. Antagonistic Activity of Bacteriocins Against Neisseria Gonorrhoeae Copenhagen, Denmark: P2154 ECCMID 2023; 2023
    [Google Scholar]
26. Schmidt JW, Greenough A, Burns M, Luteran AE, McCafferty DG. Generation of ramoplanin-resistant Staphylococcus aureus. FEMS Microbiol Lett 2010; 310:104–111 [View Article] [PubMed]
    [Google Scholar]